Vetnostrum Animal Health Co., Ltd. (TPE:6936)

Taiwan · Delayed Price · Currency is TWD

32.40

+0.20 (0.62%)

Oct 8, 2026, 1:30 PM CST

Market Cap	2.36B -7.2%
Revenue (ttm)	1.49B +10.1%
Net Income	161.63M +25.9%
EPS	2.22 +16.7%
Shares Out	72.80M
PE Ratio	14.60
Forward PE	n/a
Dividend	1.51 (4.66%)
Ex-Dividend Date	Jun 9, 2026

Volume	18,724
Open	32.00
Previous Close	32.20
Day's Range	32.00 - 32.45
52-Week Range	31.00 - 46.20
Beta	0.10
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 9, 2026

About Vetnostrum Animal Health

Vetnostrum Animal Health Co., Ltd. engages in the import, manufacture, and sale of animal medicines, health food, feed additives, and feed. It offers antibiotics, hormonal preparations, topical disinfectants, and drugs for anti-inflammatory, deworming, anti-fungal, antiprotozoal, etc; vitamins, minerals, and amino acids for regular supplementary; and non-medicated feed additives for swine, cattle and sheep, poultry, pet, and aquatic animals. The company was founded in 2012 and is based in Hsinchu City, Taiwan. Vetnostrum Animal Health Co., Ltd.... [Read more]

Industry Farm Products

Sector Consumer Staples

Founded 2012

Employees 195

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 6936

Full Company Profile

Financial Performance

In 2025, Vetnostrum Animal Health's revenue was 1.42 billion, an increase of 9.43% compared to the previous year's 1.29 billion. Earnings were 128.85 million, a decrease of -5.68%.

Financial Statements